Nothing Special   »   [go: up one dir, main page]

Keeler et al., 2003 - Google Patents

The tertiary structure and backbone dynamics of human prolactin

Keeler et al., 2003

Document ID
5569542767978939685
Author
Keeler C
Dannies P
Hodsdon M
Publication year
Publication venue
Journal of molecular biology

External Links

Snippet

Human prolactin is a 199-residue (23kDa) protein closely related to growth hormone and placental lactogen with properties and functions resembling both a hormone and a cytokine. As a traditional hormone, prolactin is produced by lactotrophic cells in the pituitary and …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/746—Erythropoetin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures

Similar Documents

Publication Publication Date Title
Keeler et al. The tertiary structure and backbone dynamics of human prolactin
Teilum et al. Solution structure of human prolactin
Klaus et al. The three-dimensional high resolution structure of human interferon α-2a determined by heteronuclear NMR spectroscopy in solution
Bader et al. Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formation
Gagné et al. Structures of the troponin C regulatory domains in the apo and calcium-saturated states
Fiori et al. Increasing sequence length favors. alpha.-helix over 310-helix in alanine-based peptides: Evidence for a length-dependent structural transition
Cuff et al. Crystal structure of a functional unit from Octopus hemocyanin
Dagil et al. The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor
US7354769B2 (en) Crystallization of IGF-1
Kuwata et al. α→ β transition of β-lactoglobulin as evidenced by heteronuclear NMR
Oliveira et al. Crystal structures of bovine β‐lactoglobulin in the orthorhombic space group C2221: Structural differences between genetic variants A and B and features of the Tanford transition
Byeon et al. A protein contortionist: core mutations of GB1 that induce dimerization and domain swapping
Thompson et al. Crystal structure of cellular retinoic acid binding protein I shows increased access to the binding cavity due to formation of an intermolecular β-sheet
Spadaccini et al. Solution structure of a sweet protein: NMR study of MNEI, a single chain monellin
Kasimova et al. NMR studies of the backbone flexibility and structure of human growth hormone: a comparison of high and low pH conformations
Starovasnik et al. Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states
Jacoby et al. Structure and Dynamics of a Protein Assembly. 1H-NMR Studies of the 36 kDaR6Insulin Hexamer
Hua et al. Mini-proinsulin and mini-IGF-I: homologous protein sequences encoding non-homologous structures
AU2002255508A1 (en) Crystallization of IGF-1
Hoshino et al. Identification of the phospholipid-binding site of human β2-glycoprotein I domain V by heteronuclear magnetic resonance
Olsen et al. The relationship between insulin bioactivity and structure in the NH2-terminal A-chain helix
Wu et al. NMR structure of tissue inhibitor of metalloproteinases-1 implicates localized induced fit in recognition of matrix metalloproteinases
Jakobsson et al. The crystal structure of Echinococcus granulosus fatty-acid-binding protein 1
JP2005506960A (en) Solution structure of IL-13 and use thereof
Roy et al. Real-time NMR kinetic studies provide global and residue-specific information on the non-cooperative unfolding of the β-trefoil protein, interleukin-1β